|
1
|
Mizrahi JD, Surana R, Valle JW and Shroff
RT: Pancreatic cancer. Lancet. 395:2008–2020. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jain T and Dudeja V: The war against
pancreatic cancer in 2020-advances on all fronts. Nat Rev
Gastroenterol Hepatol. 18:99–100. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bhave P, Pallan L, Long GV, Menzies AM,
Atkinson V, Cohen JV, Sullivan RJ, Chiarion-Sileni V, Nyakas M,
Kahler K, et al: Melanoma recurrence patterns and management after
adjuvant targeted therapy: A multicentre analysis. Br J Cancer.
124:574–580. 2021. View Article : Google Scholar :
|
|
4
|
Chan A, Moy B, Mansi J, Ejlertsen B,
Holmes FA, Chia S, Iwata H, Gnant M, Loibl S, Barrios CH, et al:
Final efficacy results of neratinib in HER2-positive hormone
receptor-positive early-stage breast cancer from the phase III
ExteNET trial. Clin Breast Cancer. 21:80–91.e7. 2021. View Article : Google Scholar
|
|
5
|
Garcia Campelo MR, Lin HM, Zhu Y, Pérol M,
Jahanzeb M, Popat S, Zhang P and Camidge DR: Health-related quality
of life in the randomized phase III trial of brigatinib vs
crizotinib in advanced ALK inhibitor-naive ALK + non-small cell
lung cancer (ALTA-1L). Lung Cancer. 155:68–77. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rhee H, Kim HY, Choi JH, Woo HG, Yoo JE,
Nahm JH, Choi JS and Park YN: Keratin 19 expression in
hepatocellular carcinoma is regulated by fibroblast-derived HGF via
a MET-ERK1/2AP1 and SP1 axis. Cancer Res. 78:1619–1631. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kim H, Choi GH, Na DC, Ahn EY, Kim GI, Lee
JE, Cho JY, Yoo JE, Choi JS and Park YN: Human hepatocellular
carcinomas with 'Stemness'-related marker expression: Keratin 19
expression and a poor prognosis. Hepatology. 54:1707–1717. 2011.
View Article : Google Scholar
|
|
8
|
Kawai T, Yasuchika K, Ishii T, Katayama H,
Yoshitoshi EY, Ogiso S, Kita S, Yasuda K, Fukumitsu K, Mizumoto M,
et al: Keratin 19, a cancer stem cell marker in human
hepatocellular carcinoma. Clin Cancer Res. 21:3081–3091. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
10
|
Hu S, Chen Z, Gu J, Tan L, Zhang M and Lin
W: TLE2 is associated with favorable prognosis and regulates cell
growth and gemcitabine sensitivity in pancreatic cancer. Ann Transl
Med. 8:10172020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang XK, Zhang YW, Wang CM, Li B, Zhang
TZ, Zhou WJ, Cheng LJ, Huo MY, Zhang CH and He YL: METTL16 promotes
cell proliferation by up-regulating cyclin D1 expression in gastric
cancer. J Cell Mol Med. 25:6602–6617. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhao R, Liu Y, Wu C, Li M, Wei Y, Niu W,
Yang J, Fan S, Xie Y, Li H, et al: BRD7 promotes cell proliferation
and tumor growth through stabilization of c-Myc in colorectal
cancer. Front Cell Dev Biol. 9:6593922021. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Warren CFA, Wong-Brown MW and Bowden NA:
BCL-2 family isoforms in apoptosis and cancer. Cell Death Dis.
10:1772019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Edlich F: BCL-2 proteins and apoptosis:
Recent insights and unknowns. Biochem Biophys Res Commun.
500:26–34. 2018. View Article : Google Scholar
|
|
15
|
Chen XL, Cheng QY, She MR, Wang Q, Huang
XH, Cao LQ, Fu XH and Chen JS: Expression of sonic hedgehog
signaling components in hepatocellular carcinoma and
cyclopamine-induced apoptosis through Bcl-2 downregulation in
vitro. Arch Med Res. 41:315–323. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gupta GP, Nguyen DX, Chiang AC, Bos PD,
Kim JY, Nadal C, Gomis RR, Manova-Todorova K and Massagué J:
Mediators of vascular remodelling co-opted for sequential steps in
lung metastasis. Nature. 446:765–770. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hiratsuka S, Nakamura K, Iwai S, Murakami
M, Itoh T, Kijima H, Shipley JM, Senior RM and Shibuya M: MMP9
induction by vascular endothelial growth factor receptor-1 is
involved in lung-specific metastasis. Cancer Cell. 2:289–300. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bausch D, Fritz S, Bolm L, Wellner UF,
Fernandez-Del-Castillo C, Warshaw AL, Thayer SP and Liss AS:
Hedgehog signaling promotes angiogenesis directly and indirectly in
pancreatic cancer. Angiogenesis. 23:479–492. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Richtig G, Aigelsreiter AM, Asslaber M,
Weiland T, Pichler M, Eberhard K, Sygulla S, Schauer S, Hoefler G
and Aigelsreiter A: Hedgehog pathway proteins SMO and GLI
expression as prognostic markers in head and neck squamous cell
carcinoma. Histopathology. 75:118–127. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Feng J, Rao M, Wang M, Liang L, Chen Z,
Pang X, Lu W and Sun Z: Triptolide suppresses pancreatic cancer
cell proliferation by inhibiting hedgehog signaling pathway
activity. Sci China Life Sci. 62:1409–1412. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lospinoso Severini L, Quaglio D, Basili I,
Ghirga F, Bufalieri F, Caimano M, Balducci S, Moretti M, Romeo I,
Loricchio E, et al: A Smo/Gli multitarget hedgehog pathway
inhibitor impairs tumor growth. Cancers (Basel). 11:15182019.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wu X, Xiao S, Zhang M, Yang L, Zhong J, Li
B, Li F, Xia X, Li X, Zhou H, et al: A novel protein encoded by
circular SMO RNA is essential for Hedgehog signaling activation and
glioblastoma tumorigenicity. Genome Biol. 22:332021. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang C, Zheng X, Ye K, Sun Y, Lu Y, Fan Q
and Ge H: miR-135a inhibits the invasion and migration of
esophageal cancer stem cells through the Hedgehog signaling pathway
by targeting Smo. Mol Ther Nucleic Acids. 19:841–852. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Guimaraes VSN, Vidal MTA, de Faro Valverde
L, de Oliveira MG, de Oliveira Siquara, da Rocha L, Coelho PLC,
Soares FA, de Freitas Souza BS, Bezerra DP, Coletta RD, et al:
Hedgehog pathway activation in oral squamous cell carcinoma:
Cancer-associated fibroblasts exhibit nuclear GLI-1 localization. J
Mol Histol. 51:675–684. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Doheny D, Manore SG, Wong GL and Lo HW:
Hedgehog signaling and truncated GLI1 in cancer. Cells. 9:21142020.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Montalto FI and De Amicis F: Cyclin D1 in
cancer: A molecular connection for cell cycle control, adhesion and
invasion in tumor and stroma. Cells. 9:26482020. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yenmiş G, Beşli N, Yaprak Saraç E,
Hocaoğlu Emre FS, Şenol K and Kanıgür G: Metformin promotes
apoptosis in primary breast cancer cells by downregulation of
cyclin D1 and upregulation of P53 through an AMPK-alpha independent
mechanism. Turk J Med Sci. 51:826–834. 2021. View Article : Google Scholar
|
|
28
|
Zhong Y, Yang L, Xiong F, He Y, Tang Y,
Shi L, Fan S, Li Z, Zhang S, Gong Z, et al: Long non-coding RNA
AFAP1-AS1 accelerates lung cancer cells migration and invasion by
interacting with SNIP1 to upregulate c-Myc. Signal Transduct Target
Ther. 6:2402021. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mondal S, Adhikari N, Banerjee S, Amin SA
and Jha T: Matrix metalloproteinase-9 (MMP-9) and its inhibitors in
cancer: A minireview. Eur J Med Chem. 194:1122602020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ren F, Tang R, Zhang X, Madushi WM, Luo D,
Dang Y, Li Z, Wei K and Chen G: Overexpression of MMP family
members functions as prognostic biomarker for breast cancer
patients: A systematic review and meta-analysis. PLoS One.
10:e01355442015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang J, Wang R, Cheng L and Xu H:
Celastrol inhibit the proliferation, invasion and migration of
human cervical HeLa cancer cells through down-regulation of MMP-2
and MMP-9. J Cell Mol Med. 25:5335–5338. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chuang YC, Hsieh MC, Lin CC, Lo YS, Ho HY,
Hsieh MJ and Lin JT: Pinosylvin inhibits migration and invasion of
nasopharyngeal carcinoma cancer cells via regulation of
epithelial-mesenchymal transition and inhibition of MMP-2. Oncol
Rep. 46:1432021. View Article : Google Scholar :
|
|
33
|
Niyaz M, Khan MS, Wani RA, Shah OJ and
Mudassar S: Sonic Hedgehog protein is frequently up-regulated in
pancreatic cancer compared to colorectal cancer. Pathol Oncol Res.
26:551–557. 2020. View Article : Google Scholar
|
|
34
|
Mohd Ariffin K, Abd Ghani F, Hussin H, Md
Said S, Yunus R, Veerakumarasivam A and Abdullah MA: Hedgehog
signalling molecule, SMO is a poor prognostic marker in bladder
cancer. Malays J Pathol. 43:49–54. 2021.PubMed/NCBI
|
|
35
|
Kasiri S, Chen B, Wilson AN, Reczek A,
Mazambani S, Gadhvi J, Noel E, Marriam U, Mino B, Lu W, et al:
Stromal Hedgehog pathway activation by IHH suppresses lung
adenocarcinoma growth and metastasis by limiting reactive oxygen
species. Oncogene. 39:3258–3275. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Huang H, Yu H, Lin L, Chen J and Zhu P:
Protective effect of sonic hedgehog against oxidized low-density
lipoprotein-induced endothelial apoptosis: Involvement of NF-κB and
Bcl-2 signaling. Int J Mol Med. 45:1864–1874. 2020.PubMed/NCBI
|
|
37
|
Bigelow RL, Chari NS, Unden AB, Spurgers
KB, Lee S, Roop DR, Toftgard R and McDonnell TJ: Transcriptional
regulation of bcl-2 mediated by the sonic hedgehog signaling
pathway through gli-1. J Biol Chem. 279:1197–1205. 2004. View Article : Google Scholar
|
|
38
|
Han ME, Lee YS, Baek SY, Kim BS, Kim JB
and Oh SO: Hedgehog signaling regulates the survival of gastric
cancer cells by regulating the expression of Bcl-2. Int J Mol Sci.
10:3033–3043. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Jiang YJ, Lee CL, Wang Q, Zhou ZW, Yang F,
Jin C and Fu DL: Establishment of an orthotopic pancreatic cancer
mouse model: Cells suspended and injected in Matrigel. World J
Gastroenterol. 20:9476–9485. 2014. View Article : Google Scholar :
|
|
40
|
Tang S, Hang Y, Ding L, Tang W, Yu A,
Zhang C, Sil D, Xie Y and Oupický D: Intraperitoneal siRNA
nanoparticles for augmentation of gemcitabine efficacy in the
treatment of pancreatic cancer. Mol Pharm. 18:4448–4458. 2021.
View Article : Google Scholar : PubMed/NCBI
|
